“Results of this cluster trial demonstrate that salt substitution was safe, along with reduced risks of stroke recurrence and death, which underscores large health gains from scaling up this low-cost ...

(HealthDay News) — Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection is associated with more rapid progression of coronary artery lesion-based plaque volume, according to a study ...

Prevalence of preterm birth and low birth weight slightly higher, but no difference seen in prevalence of birth defects ...

(HealthDay News) — For individuals with type 1 diabetes, intraindividual body weight variability, or body weight cycling, is associated with an increased risk for renal events, according to a study ...

(HealthDay News) — Life’s Crucial 9 (LC9), a recently proposed method for assessing cardiovascular health, has a strong negative correlation with overactive bladder (OAB), which is partially mediated ...

Dementia cases had lower BMI and waist circumference and faster declines; HDL levels generally higher predementia ...

Among patients hospitalized with COVID-19, particularly those who were also receiving noninvasive ventilation or invasive mechanical ventilation, dexamethasone was associated with reduced mortality.

Among patients with chemotherapy-induced peripheral neuropathy, those treated with platinum-based agents, taxanes had highest prevalence. (HealthDay News) — The pooled prevalence of chronic ...

At the same time, incidence of distant-stage prostate cancer increased. (HealthDay News) — Distant-stage prostate cancer increased and mortality rates plateaued throughout California during the ...

Elevated LDL cholesterol, total cholesterol, triglycerides linked to reduced risk for glaucoma. (HealthDay News) — Elevated high-density lipoprotein cholesterol (HDL-C) is associated with an ...

As baseline levels of IL-6 prior to hemodialysis AVF creation increase, so does the risk for AVF failure. Elevated levels of interleukin-6 (IL-6) prior to surgery to create an arteriovenous ...

SGLT-2 inhibitors, compared with DPP-4 inhibitors, were associated with a lower risk for liver cirrhosis among patients with type 2 diabetes. Sodium-glucose cotransporter 2 (SGLT-2) inhibitors ...